HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $26 | -99.9% | 22 | -99.9% | 0.00% | – |
Q1 2023 | $51,391 | -97.9% | 34,034 | -96.6% | 0.00% | -100.0% |
Q4 2022 | $2,500,000 | -85.4% | 1,000,000 | -37.5% | 0.01% | -89.3% |
Q3 2021 | $17,109,000 | +352.9% | 1,600,486 | +557.4% | 0.08% | +341.2% |
Q2 2021 | $3,778,000 | +258.4% | 243,449 | +274.5% | 0.02% | +240.0% |
Q1 2021 | $1,054,000 | -54.9% | 65,000 | -41.1% | 0.01% | -54.5% |
Q4 2020 | $2,336,000 | -39.7% | 110,382 | -57.8% | 0.01% | -45.0% |
Q3 2020 | $3,873,000 | -8.8% | 261,341 | +50.5% | 0.02% | +5.3% |
Q1 2019 | $4,245,000 | +446.3% | 173,700 | +768.5% | 0.02% | +533.3% |
Q2 2018 | $777,000 | -61.2% | 20,000 | -85.0% | 0.00% | -72.7% |
Q1 2017 | $2,002,000 | +7314.8% | 133,483 | +12034.8% | 0.01% | – |
Q3 2015 | $27,000 | -99.7% | 1,100 | -99.6% | 0.00% | -100.0% |
Q2 2015 | $7,837,000 | +7.7% | 251,500 | -49.7% | 0.05% | +8.0% |
Q1 2015 | $7,275,000 | +41.8% | 500,000 | -2.0% | 0.05% | +38.9% |
Q4 2014 | $5,132,000 | – | 510,100 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |